Article
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.
The Journal of molecular diagnostics : JMD - 1 Jul 2007
Ogino Shuji, Kawasaki Takako, Kirkner Gregory J, Kraft Peter, Loda Massimo, Fuchs Charles S
Abstract excerpt
The CpG island methylator phenotype (CIMP or CIMP-high) with extensive promoter methylation is a distinct phenotype in colorectal cancer. However, a choice of markers for CIMP has been controversial. A recent extensive investigation has selected five methylation markers (CACNA1G, IGF2, NEUROG1, RUNX3, and SOCS1) as surrogate markers for epigenomic aberrations in tumor. The use of these markers as a CIMP-specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
